Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Insulin’s direct hepatic effect explains the inhibition of glucose production caused by insulin secretion
Dale S. Edgerton, … , Richard M. O’Brien, Alan D. Cherrington
Dale S. Edgerton, … , Richard M. O’Brien, Alan D. Cherrington
Published March 23, 2017
Citation Information: JCI Insight. 2017;2(6):e91863. https://doi.org/10.1172/jci.insight.91863.
View: Text | PDF
Research Article Endocrinology Metabolism

Insulin’s direct hepatic effect explains the inhibition of glucose production caused by insulin secretion

  • Text
  • PDF
Abstract

Insulin can inhibit hepatic glucose production (HGP) by acting directly on the liver as well as indirectly through effects on adipose tissue, pancreas, and brain. While insulin’s indirect effects are indisputable, their physiologic role in the suppression of HGP seen in response to increased insulin secretion is not clear. Likewise, the mechanisms by which insulin suppresses lipolysis and pancreatic α cell secretion under physiologic circumstances are also debated. In this study, insulin was infused into the hepatic portal vein to mimic increased insulin secretion, and insulin’s indirect liver effects were blocked either individually or collectively. During physiologic hyperinsulinemia, plasma free fatty acid (FFA) and glucagon levels were clamped at basal values and brain insulin action was blocked, but insulin’s direct effects on the liver were left intact. Insulin was equally effective at suppressing HGP when its indirect effects were absent as when they were present. In addition, the inhibition of lipolysis, as well as glucagon and insulin secretion, did not require CNS insulin action or decreased plasma FFA. This indicates that the rapid suppression of HGP is attributable to insulin’s direct effect on the liver and that its indirect effects are redundant in the context of a physiologic increase in insulin secretion.

Authors

Dale S. Edgerton, Guillaume Kraft, Marta Smith, Ben Farmer, Phillip E. Williams, Katie C. Coate, Richard L. Printz, Richard M. O’Brien, Alan D. Cherrington

×

Figure 2

Effect of a fall in glucagon on hepatic glucose production during hyperinsulinemia.

Options: View larger image (or click on image) Download as PowerPoint
Effect of a fall in glucagon on hepatic glucose production during hyperi...
Insulin was elevated 6-fold by portal vein insulin infusion in conscious dogs in the INS control (n = 6) and INS+GGN glucagon-clamp (n = 5) groups. Glucagon was infused into the portal vein in the latter to prevent a decrease in its level at the liver. (A) Arterial and hepatic sinusoidal plasma insulin levels. (B) Arterial plasma glucose levels and peripheral glucose infusion rate. (C) Arterial plasma C-peptide and hepatic sinusoidal plasma glucagon levels. (D) Arterial plasma free fatty acid (FFA) levels and net hepatic FFA uptake. (E) Arterial blood glycerol levels and net glycerol hepatic uptake. (F) Arterial blood lactate levels and net hepatic lactate uptake. (G) Intrahepatic gluconeogenic and glycogenolytic fluxes. (H) Net hepatic glucose balance and hepatic glucose production. Values are means ± SEM. *Denotes a difference (P < 0.05; 2-way repeated measure ANOVA) between groups.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts